Immunotoxins composed of monoclonal antibodies (mAbs) and various toxins have been developed for the treatment of malignancies. We investigated the efficacy of three ricin toxin A-chain (RTA)-containing immunotoxins (ITs) conjugated from mAbs which ...
Usui, Hiroko, Hakomori, Sen-Itiroh
core
Taming Bacterial Toxins into an Anticancer Platform. [PDF]
Yang C, Chen C.
europepmc +1 more source
Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins. [PDF]
Misra R +6 more
europepmc +1 more source
Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review. [PDF]
Polavarapu H, Hall WA.
europepmc +1 more source
Single-Chain Variable Fragment Fusion Proteins for Targeted Delivery and Therapy. [PDF]
Yang L, Yin Y, Liu X, Guo B.
europepmc +1 more source
Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance. [PDF]
Wang X, Pešić M, Podolski-Renić A.
europepmc +1 more source
Proteoglycans as Regulators of Receptor Trafficking and Spatial Signaling in Cancer. [PDF]
Berdiaki A +6 more
europepmc +1 more source
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]
Narbona J +5 more
europepmc +1 more source
Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy. [PDF]
Wang Q +9 more
europepmc +1 more source
Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]
Faraz A +4 more
europepmc +1 more source

